However, the increased serum S100A8 level may be insufficient in its role as an SLE-specific biomarker, given that it is also observed in many inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease (14, 15). This evidence concerns the gene S100A8 and inflammatory bowel disease.